Managed to get my allocation on application. Very happy with the outcome.
Looking forward to seeing how the Noxopharm plan progresses. Key points for me are:
> NOX66 is a novel formulation of an effective compound - idronoxil
> Broad application across a range of cancers
> Trials in Eastern Europe is lower cost, the process quicker and apparently the ‘quality’ of patients is better since this may be their first treatment instead of last
> GK experienced at Human Trials and bringing drugs to market
All thumbs up for me plus a low enterprise value mean a strong investment opportunity I think. Let’s see if we start getting some good news in 2016 to set us up for a strong 2017
GLTA
- Forums
- ASX - By Stock
- Listing today
NOX
noxopharm limited
Add to My Watchlist
2.22%
!
9.2¢

Managed to get my allocation on application. Very happy with the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
0.002(2.22%) |
Mkt cap ! $26.88M |
Open | High | Low | Value | Volume |
9.1¢ | 9.2¢ | 9.1¢ | $7.772K | 85.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 166444 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.2¢ | 855 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 166444 | 0.090 |
1 | 70454 | 0.088 |
2 | 83000 | 0.087 |
1 | 11764 | 0.085 |
1 | 12345 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.092 | 855 | 1 |
0.095 | 8706 | 1 |
0.096 | 57000 | 1 |
0.099 | 90000 | 1 |
0.100 | 57999 | 3 |
Last trade - 12.56pm 18/09/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |